In addition to stimulation of proliferation and induction of DNA damage in both ER-positive and ER-negative cells [1, 2], estrogen activates an epithelial-mesenchymal transition (EMT) program in ER-positive breast cancer cells to promote their stemness and invasiveness in vitro [5, 6]. The gene discussed is ESR1; the disease is breast carcinoma.